This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Regional De Lutte Contre Le Cancer “Val D'aurelle-Paul Lamarque”, National Institute of Health and Medical Research, Universitè De Montpellier. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,853 
1 out of 298 
Years Active: 2011
Title: Philippe Gauthier: Innovator in Cancer Immunotherapy
Introduction
Philippe Gauthier is a notable inventor based in Grabels, France. He has made significant contributions to the field of cancer immunotherapy, particularly through his innovative work on antibody fragments.
Latest Patents
Gauthier holds a patent for "Human anti-idiotypic antibody fragments that mimic HER-2/neu." This invention relates to human anti-idiotypic antibody fragments, especially scFv, characterized by the ability to mimic the Her-2/neu tumor-associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients who are positive for Her-2/neu. He has 1 patent to his name.
Career Highlights
Throughout his career, Philippe Gauthier has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre Régional de Lutte Contre Le Cancer “Val D'Aurelle-Paul Lamarque.” His work in these institutions has contributed to advancements in medical research and cancer treatment.
Collaborations
Gauthier has collaborated with notable professionals in his field, including André Pelegrin and Mickaël Coelho. These partnerships have further enhanced his research and development efforts.
Conclusion
Philippe Gauthier's innovative work in the field of cancer immunotherapy highlights his commitment to improving patient outcomes. His contributions through patents and collaborations continue to influence the medical research landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile